Not only Mohammed Nalapad; BJP MP’s son also involved: Advocate

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.

Bengaluru, Apr 1: Karnataka government along with BBMP has asked project contractors, builders and developers in the city not to send their labourers to their native place and instead provide them with amenities like food and shelter in this lockdown period.

It was also warned with legal action would be taken against them if they violating the instructions from the government .

Bengaluru, Apr 14: The Karnataka government has decided to adopt “remote monitoring” of COVID-19 positive patients in order to ensure the safety of healthcare professionals - the frontline warriors against the pandemic.

Two doctors treating COVID-19 patients tested positive recently and in to check such instances in future, the Department of Medical Education is planning remote monitoring, which reduces doctors’ exposure to patients.

Medical Education Minister Dr K Sudhakar has consulted some of the doctors in the United States who are already using this technology to treat the COVID-19 positive cases. The minister is also having a meeting with representatives of some of the companies which provide such technology.

“I spoke to a team of epidemiologists and heads of certain departments at the United States to know about the remote monitoring technology they are using. I am also meeting the representatives of a few such companies which can provide us with the technology at our hospitals,”  Dr Sudhakar said.

Track state-wise coronavirus cases here

The minister added, “We have heard reports of many doctors and other health professionals succumbing to COVID-19. We don’t want to take risk.” Explaining the technology, Dr Sachidanand, Vice Chancellor of Rajiv Gandhi University of Health Sciences said that remote monitoring uses a software with which specialist doctors can monitor health condition of patients and treat them by not getting exposed directly.

The presence of all the doctors in COVID-19 is not necessary when patients are monitored remotely.